A quantitative approach for measuring the reservoir of latent HIV-1 proviruses (original) (raw)
Data availability
The IPDA was developed through an analysis of published near full genome HIV-1 sequences (refs 8,9, GenBank accession numbers KX505390–KX505744 and KU677989–KU678196, respectively). All other data are available from the corresponding author upon reasonable request.
References
- Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295–1300 (1997).
Article ADS CAS Google Scholar - Chun, T. W. et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl Acad. Sci. USA 94, 13193–13197 (1997).
Article ADS CAS Google Scholar - Wong, J. K. et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291–1295 (1997).
Article ADS CAS Google Scholar - Archin, N. M. et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 487, 482–485 (2012).
Article ADS CAS Google Scholar - Borducchi, E. N. et al. Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys. Nature 540, 284–287 (2016).
Article ADS CAS Google Scholar - Procopio, F. A. et al. A novel assay to measure the magnitude of the inducible viral reservoir in HIV-infected individuals. EBioMedicine 2, 874–883 (2015).
Article Google Scholar - Ho, Y. C. et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155, 540–551 (2013).
Article CAS Google Scholar - Bruner, K. M. et al. Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat. Med. 22, 1043–1049 (2016).
Article CAS Google Scholar - Imamichi, H. et al. Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy. Proc. Natl Acad. Sci. USA 113, 8783–8788 (2016).
Article CAS Google Scholar - Sheehy, A. M., Gaddis, N. C., Choi, J. D. & Malim, M. H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646–650 (2002).
Article ADS CAS Google Scholar - Jordan, A., Bisgrove, D. & Verdin, E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22, 1868–1877 (2003).
Article CAS Google Scholar - Finzi, D. et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5, 512–517 (1999).
Article CAS Google Scholar - Crooks, A. M. et al. Precise quantitation of the latent HIV-1 reservoir: implications for eradication strategies. J. Infect. Dis. 212, 1361–1365 (2015).
Article CAS Google Scholar - Maldarelli, F. et al. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science 345, 179–183 (2014).
Article ADS CAS Google Scholar - Wagner, T. A. et al. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science 345, 570–573 (2014).
Article ADS CAS Google Scholar - Bui, J. K. et al. Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir. PLoS Pathog. 13, e1006283 (2017).
Article Google Scholar - Lorenzi, J. C. et al. Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA. Proc. Natl Acad. Sci. USA 113, E7908–E7916 (2016).
Article CAS Google Scholar - Hosmane, N. N. et al. Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: potential role in latent reservoir dynamics. J. Exp. Med. 214, 959–972 (2017).
Article CAS Google Scholar - Wang, Z. et al. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane. Proc. Natl Acad. Sci. USA 115, E2575–E2584 (2018).
Article CAS Google Scholar - Chomont, N. et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15, 893–900 (2009).
Article CAS Google Scholar - Cohn, L. B. et al. HIV-1 integration landscape during latent and active infection. Cell 160, 420–432 (2015).
Article CAS Google Scholar - Ho, D. D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123–126 (1995).
Article ADS CAS Google Scholar - Wei, X. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117–122 (1995).
Article ADS CAS Google Scholar - Simonetti, F. R. et al. Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo. Proc. Natl Acad. Sci. USA 113, 1883–1888 (2016).
Article ADS CAS Google Scholar - Pollack, R. A. et al. Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes, which shape the proviral landscape. Cell Host Microbe 21, 494–506 (2017).
Article CAS Google Scholar - Berry, C. C. et al. Estimating abundances of retroviral insertion sites from DNA fragment length data. Bioinformatics 28, 755–762 (2012).
Article CAS Google Scholar - Detels, R. et al. The multicenter AIDS Cohort Study, 1983 to … Public Health 126, 196–198 (2012).
Article CAS Google Scholar - Rose, P. P. & Korber, B. T. Detecting hypermutations in viral sequences with an emphasis on G→A hypermutation. Bioinformatics 16, 400–401 (2000).
Article CAS Google Scholar - Laird, G. M., Rosenbloom, D. I., Lai, J., Siliciano, R. F. & Siliciano, J. D. Measuring the frequency of latent HIV-1 in resting CD4+ T cells using a limiting dilution coculture assay. Methods Mol. Biol. 1354, 239–253 (2016).
Article CAS Google Scholar - Laird, G. M. et al. Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay. PLoS Pathog. 9, e1003398 (2013).
Article CAS Google Scholar - Rosenbloom, D. I. et al. Designing and interpreting limiting dilution assays: general principles and applications to the latent reservoir for human immunodeficiency virus-1. Open Forum Infect. Dis. 2, ofv123 (2015).
Article Google Scholar - Sallusto, F., Lenig, D., Förster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708–712 (1999).
Article ADS CAS Google Scholar - Durand, C. M. et al. HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy. J. Infect. Dis. 205, 1014–1018 (2012).
Article CAS Google Scholar - Lewinski, M. K. et al. Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J. Virol. 79, 6610–6619 (2005).
Article CAS Google Scholar - Sherman, E. et al. INSPIIRED: a pipeline for quantitative analysis of sites of new DNA integration in cellular genomes. Mol. Ther. Methods Clin. Dev. 4, 39–49 (2017).
Article ADS CAS Google Scholar
Acknowledgements
We thank D. Finzi of NIAID for discussions leading to this work. This work was supported by the NIH Martin Delaney I4C (UM1 AI126603), Beat-HIV (UM1 AI126620) and DARE (UM1 AI12661) Collaboratories, by NIH grant 43222, by the Howard Hughes Medical Institute and the Bill and Melinda Gates Foundation (OPP1115715), and by NIH SBIR grants R43AI124996 and R44AI124996 and NSF grants 1621633 and 1738428 to Accelevir Diagnostics. Samples for some study participants were obtained from the Baltimore-Washington DC Center of the Multicenter AIDS Cohort Study (MACS) supported by NIH grants U01-AI-35042 and UL1-RR025005 (ICTR).
Author information
Author notes
- Katherine M. Bruner
Present address: Department of Molecular Biosciences, University of Texas, Austin, TX, USA - Ya-Chi Ho
Present address: Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, CT, USA - These authors contributed equally: Katherine M. Bruner, Zheng Wang
Authors and Affiliations
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Katherine M. Bruner, Zheng Wang, Francesco R. Simonetti, Alexandra M. Bender, Kyungyoon J. Kwon, Srona Sengupta, Emily J. Fray, Subul A. Beg, Annukka A. R. Antar, Katharine M. Jenike, Lynn N. Bertagnolli, Adam A. Capoferri, Joshua T. Kufera, Andrew Timmons, Ya-Chi Ho, Joel N. Blankson, Janet D. Siliciano & Robert F. Siliciano - Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
Christopher Nobles, John Gregg & Frederic D. Bushman - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Nikolas Wada - Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Hao Zhang & Joseph B. Margolick - Department of Medicine, University of California San Francisco, San Francisco, CA, USA
Steven G. Deeks - Accelevir Diagnostics, Baltimore, MD, USA
Gregory M. Laird - Howard Hughes Medical Institute, Baltimore, MD, USA
Robert F. Siliciano
Authors
- Katherine M. Bruner
You can also search for this author inPubMed Google Scholar - Zheng Wang
You can also search for this author inPubMed Google Scholar - Francesco R. Simonetti
You can also search for this author inPubMed Google Scholar - Alexandra M. Bender
You can also search for this author inPubMed Google Scholar - Kyungyoon J. Kwon
You can also search for this author inPubMed Google Scholar - Srona Sengupta
You can also search for this author inPubMed Google Scholar - Emily J. Fray
You can also search for this author inPubMed Google Scholar - Subul A. Beg
You can also search for this author inPubMed Google Scholar - Annukka A. R. Antar
You can also search for this author inPubMed Google Scholar - Katharine M. Jenike
You can also search for this author inPubMed Google Scholar - Lynn N. Bertagnolli
You can also search for this author inPubMed Google Scholar - Adam A. Capoferri
You can also search for this author inPubMed Google Scholar - Joshua T. Kufera
You can also search for this author inPubMed Google Scholar - Andrew Timmons
You can also search for this author inPubMed Google Scholar - Christopher Nobles
You can also search for this author inPubMed Google Scholar - John Gregg
You can also search for this author inPubMed Google Scholar - Nikolas Wada
You can also search for this author inPubMed Google Scholar - Ya-Chi Ho
You can also search for this author inPubMed Google Scholar - Hao Zhang
You can also search for this author inPubMed Google Scholar - Joseph B. Margolick
You can also search for this author inPubMed Google Scholar - Joel N. Blankson
You can also search for this author inPubMed Google Scholar - Steven G. Deeks
You can also search for this author inPubMed Google Scholar - Frederic D. Bushman
You can also search for this author inPubMed Google Scholar - Janet D. Siliciano
You can also search for this author inPubMed Google Scholar - Gregory M. Laird
You can also search for this author inPubMed Google Scholar - Robert F. Siliciano
You can also search for this author inPubMed Google Scholar
Contributions
K.M.B., Z.W., G.M.L. and R.F.S. designed the study. K.M.B., Z.W., G.M.L., F.R.S., A.M.B., K.J.K., S.S., E.J.F., A.A.R.A., K.M.J., L.N.B., J.T.K. and Y.-C.H. performed experiments. K.M.B., Z.W., F.R.S., A.T., N.W., J.D.S., G.M.L. and R.F.S. analysed data. C.N., J.G. and F.D.B. provided integration site analysis. H.Z. performed cell sorting. S.A.B., A.A.C., J.B.M., J.N.B. and S.G.D. provided patient samples. K.M.B. and R.F.S. wrote the manuscript.
Corresponding author
Correspondence toRobert F. Siliciano.
Ethics declarations
Competing interests
Aspects of IPDA are subject of a patent application PCT/US16/28822 filed by Johns Hopkins University. K.M.B. and R.F.S. are inventors on this application. Accelevir Diagnostics holds an exclusive license for this patent application. G.M.L. is an employee of and shareholder in Accelevir Diagnostics. R.F.S. holds no equity interest in Accelevir Diagnostics. R.F.S. is a consultant on cure-related HIV research for Merck and Abbvie.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data figures and tables
Extended Data Fig. 1 Analysis of hypermutation.
a, Most hypermutated proviruses show both GG→AG and GA→AA patterns of hypermutation. Analysis based on hypermutated full-genome sequences in the database (n = 100). Sequences were analysed for GG→AG and GA→AA patterns using all available sequences for each clone and the Los Alamos Hypermut algorithm17. b, Hypermutation discrimination using two probes in the RRE of the env gene. The intact probe hybridizes with a region containing two adjacent APOBEC3G consensus sites (red underline) in intact proviruses. It is labelled with a fluorophore (VIC) and a quencher (Q). Also present in the reaction is a hypermutated probe that lacks the fluorophore and does not bind (arrow) to intact proviral sequences owing to G→A mutations at both APOBEC3G consensus sites. Dashed boxes indicate the nucleotide positions of sequence differences between the intact and hypermutated probes. The hypermutated probe preferentially binds to the same region in hypermutated proviruses. It lacks a fluorophore and prevents binding of the fluorophore-labelled intact probe (arrow). Therefore, no fluorescent signal is generated for 95% of hypermutated proviruses (Fig. 2f).
Extended Data Fig. 2 Plasmid controls show the specificity of the IPDA.
a, Maps of proviral plasmid control templates. Plasmids E44E11, 39G2 and 4F11 have deletions in the indicated regions (white). Plasmid 2G10 is a heavily hypermutated patient-derived sequence with G→A mutations in the probe-binding region of the env amplicon (enlarged region). Plasmid 19B3 has GA point mutations in this region. These G→A mutations (red) occur at two APOBEC3G consensus sites (TGGG, underlined) in this region. These plasmids have been previously described12,34. b–e, IPDA on plasmids representing the indicated defective proviruses showing positive droplets only in the expected quadrants.
Extended Data Fig. 3 IPDA accuracy, reproducibility and limit of quantification.
a, Correlation between expected and IPDA-measured frequencies of intact proviruses per 106 cells. Genomic DNA from uninfected donor CD4+ T cells was spiked with JLat6.3 DNA cell equivalents and subjected to a serial fourfold dilution. This material was then analysed by the IPDA, and the IPDA-measured frequencies of intact proviruses per million cells were compared to the expected frequencies (998, 249.5, 62.4, 15.6 and 3.9 intact proviruses per 106 CD4+ T cells). This experiment was performed independently three times. The agreement between the expected and IPDA-measured frequencies of intact proviruses was determined using Pearson correlation. b, Reproducibility of the IPDA across independent assay runs. Reproducibility was assessed by determining the coefficient of variation (CV) across three independent assay measurements of genomic DNA from uninfected donor CD4+ T cells spiked with JLat6.3 cell equivalents and subject to serial fourfold dilution, as described in a.
Extended Data Fig. 4 IPDA reproducibility.
a–c, Frequencies of cells containing proviruses with 3′ deletions and/or hypermutation (a), 5′ deletions (b), or no defects (intact; c) in CD4+ T cells from 28 treated patients. Each data point represents a replicate IPDA determination from a single sample from the indicated patient. The mean and s.e.m. of the replicates are plotted. The variability between patients is much greater than the variation between replicates from a single patient. Technical replicates are shown to indicate low intrinsic variability of the IPDA.
Extended Data Fig. 5 Plasmid controls confirm specificity of the IPDA.
a, Map of the plasmid pNL4-3 carrying an intact HIV-1 provirus. Positions of the Ψ (blue) and env (green) IPDA amplicons and of a distinct set of plasmid shearing control (PSC, magenta boxes) amplicons are indicated. Spacing between PSC amplicons is equal to spacing between Ψ and env amplicons. Dotted lines indicate positions of deletions in plasmids carrying previously described12 defective proviruses E44E11 and 4F12 with 5′ and 3′ deletions, respectively. b, IPDA analysis of the indicated ZraI-cut plasmids representing intact, 5′-deleted and 3′-deleted proviruses. c, Summary of droplet counts for the experiment shown in b. E44E11 and 4F12 give positive droplets only in quadrants 4 and 1 (Q4 and Q1), respectively. For pNL4-3, more than 95% of droplets are in Q2, with the remainder attributable to shearing between the Ψ and env amplicons. d, Analysis of shearing. For IPDA analysis of patient samples, shearing was measured using amplicons in the RPP30 gene (Fig. 3a, d, e). For plasmid control experiments, shearing of ZraI-cut plasmids was analysed using two sets of amplicons, the Ψ and env IPDA amplicons and the equally spaced PSC amplicons shown in a. ddPCR analysis was done on fresh (D0) maxipreps of pNL4-3 linearized with ZraI at a concentration mimicking patient samples. To assess the effects of higher levels of DNA fragmentation, IPDA analysis was also done on pNL4-3 DNA that had been incubated at 4 °C for 5 days (D5), and on pNL4-3 DNA cut with both ZraI and EcoRI (two cuts). The mean and range of duplicate determinations of the DSI is shown for each set of amplicons. The DSI was the same for the IPDA and PSC amplicons at three different levels of shearing. The DSI was used to correct the IPDA droplet counts in e. Negative values were set to 0. e, Uncorrected and DSI-corrected IPDA analysis of the intact proviral construct pNL4-3 at different levels of fragmentation. After correction, positive droplets were almost exclusively in Q2 even at higher levels of fragmentation.
Extended Data Fig. 6 Sequence analysis of Q2 proviruses.
a, Sorting of productively infected CD4+ T cells. Cell preparations with a high fraction of intact proviruses were obtained by infecting CD4+ T lymphoblasts with a replication-competent HIV-1 carrying GFP in the nef ORF (R7-GFP37). After 48 h, GFP+ cells were collected by sorting. Genomic DNA was isolated, subjected to pulse field electrophoresis to remove unintegrated intermediates, and analysed by IPDA. b, IPDA analysis of high molecular mass DNA from sorted cells. Droplets in Q1 and Q4 largely reflect the shearing of intact proviruses (DSI = 0.46) during in DNA isolation and purification. c, Frequency of intact proviruses in GFP− and GFP+ cells before and after correction for shearing. After correction for shearing, the frequency of intact proviruses in sorted GFP+ cells is close to the expected value of 1. d, Map of the HIV-1 genome in GFP-expressing HIV-1 vector R7-GFP used in a. GFP is inserted in the nef ORF. Positions of outer primers in the LTR and GFP used in single genome amplifications are indicated. e, Sequence analysis of nine independent single genomes. Arrows indicate positions of the Ψ and env IPDA amplicons. Orange lines indicate intact sequence without deletions or hypermutation and identical to R7-GFP except for single base mutations (black lines).
Extended Data Fig. 7 DSI for patient samples.
The DSI was determined by ddPCR using two amplicons in a cellular gene (RPP30) spaced at exactly the same distance as the Ψ and env amplicons. It is the fraction of templates in which DNA shearing has occurred between the amplicons. Horizontal bars indicate median and interquartile range; data from n = 62 patient samples.
Extended Data Fig. 8 In vivo decay rates of cells with intact and defective proviruses.
The frequency of cells carrying intact proviruses, proviruses with 3′ deletion and/or hypermutation (3′ del/hyper), and proviruses with 5′ deletions (5′ del) was measured in resting CD4+ T cells from patients on long-term suppressive ART. Data are plotted in terms of decay rate assuming exponential decay. Half-life values for the same decay curves are shown in Fig. 4c. Negative decay rate indicates proliferation.
Extended Data Fig. 9 Variability in decay slopes.
Shown are the mean and s.d. of the decay slopes for intact and defective proviruses in infected individuals on ART sampled longitudinally (n = 14). Analysis based on decay data in Fig. 4a.
Supplementary information
Rights and permissions
About this article
Cite this article
Bruner, K.M., Wang, Z., Simonetti, F.R. et al. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses.Nature 566, 120–125 (2019). https://doi.org/10.1038/s41586-019-0898-8
- Received: 19 April 2018
- Accepted: 04 January 2019
- Published: 30 January 2019
- Issue Date: 07 February 2019
- DOI: https://doi.org/10.1038/s41586-019-0898-8